Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

被引:46
作者
Barret, Olivier [1 ]
Alagille, David [1 ]
Sanabria, Sandra [2 ]
Comley, Robert A. [3 ]
Weimer, Robby M. [2 ]
Borroni, Edilio [3 ]
Mintun, Mark [4 ]
Seneca, Nicholas [5 ]
Papin, Caroline [1 ]
Morley, Thomas [1 ]
Marek, Ken [1 ]
Seibyl, John P. [1 ]
Tamagnan, Gilles D. [1 ]
Jennings, Danna [1 ]
机构
[1] Mol NeuroImaging LLC, 60 Temple St,Suite 8B, New Haven, CT 06510 USA
[2] Genentech Inc, Genentech Res & Early Dev, San Francisco, CA 94080 USA
[3] F Hoffmann La Roche, Konzern Hauptsitz, Pharma Res & Early Dev, Basel, Switzerland
[4] Avid Radiopharmaceut, Philadelphia, PA USA
[5] F Hoffmann La Roche, Prod Dev, Konzern Hauptsitz, Basel, Switzerland
关键词
tau protein; Alzheimer; PET; F-18-AV-1451; kinetic modeling; MILD COGNITIVE IMPAIRMENT; IMAGING AGENT; PATHOLOGY; BRAIN; T807;
D O I
10.2967/jnumed.116.182881
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
F-18-AV-1451 is currently the most widely used of several experimental tau PET tracers. The objective of this study was to evaluate F-18-AV-1451 binding with full kinetic analysis using a metabolite-corrected arterial input function and to compare parameters derived from kinetic analysis with SUV ratio (SUVR) calculated over different imaging time intervals. Methods: F-18-AV-1451 PET brain imaging was completed in 16 subjects: 4 young healthy volunteers (YHV), 4 aged healthy volunteers (AHV), and 8 Alzheimer disease (AD) subjects. Subjects were imaged for 3.5 h, with arterial blood samples obtained throughout. PET data were analyzed using plasma and reference tissue-based methods to estimate the distribution volume, binding potential (BPND), and SUVR. BPND and SUVR were calculated using the cerebellar cortex as a reference region and were compared across the different methods and across the 3 groups (YHV, AHV, and AD). Results: AD demonstrated increased F-18-AV-1451 retention compared with YHV and AHV based on both invasive and noninvasive analyses in cortical regions in which paired helical filament tau accumulation is expected in AD. A correlation of R-2 > 0.93 was found between BPND (130 min) and SUVR-1 at all time intervals. Cortical SUVR curves reached a relative plateau around 1.0-1.2 for YHV and AHV by approximately 50 min, but increased in AD by up to approximately 20% at 110-130 min and approximately 30% at 160-180 min relative to 80-100 min. Distribution volume (130 min) was lower by 30%-35% in the YHV than AHV. Conclusion: Our data suggest that although F-18-AV-1451 SUVR curves do not reach a plateau and are still increasing in AD, an SUVR calculated over an imaging window of 80-100 min (as currently used in clinical studies) provides estimates of paired helical filament tau burden in good correlation with BPND, whereas SUVR sensitivity to regional cerebral blood changes needs further investigation.
引用
收藏
页码:1124 / 1131
页数:8
相关论文
共 27 条
[1]  
Baker S, 2015, 12 INT C QUANT BRAIN
[2]  
Bohorquez S Sanabria, 2016, 10 HUM AM IM JAN 13
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808 [J].
Chien, David T. ;
Szardenings, A. Katrin ;
Bahri, Shadfar ;
Walsh, Joseph C. ;
Mu, Fanrong ;
Xia, Chunfang ;
Shankle, William R. ;
Lerner, Alan J. ;
Su, Min-Ying ;
Elizarova, Arkadij ;
Kolb, Hartmuth C. .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 38 (01) :171-184
[5]   Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807 [J].
Chien, David T. ;
Bahri, Shadfar ;
Szardenings, A. Katrin ;
Walsh, Joseph C. ;
Mu, Fanrong ;
Su, Min-Ying ;
Shankle, William R. ;
Elizarov, Arkadij ;
Kolb, Hartmuth C. .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (02) :457-468
[6]   Human Radiation Dosimetry of [18F]AV-1451(T807) to Detect Tau Pathology [J].
Choi, Jae Yong ;
Lyoo, Chul Hyoung ;
Lee, Jae Hoon ;
Cho, Hanna ;
Kim, Kyeong Min ;
Kim, Jin Su ;
Ryu, Young Hoon .
MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (04) :479-482
[7]   Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe [J].
Hammers, A ;
Allom, R ;
Koepp, MJ ;
Free, SL ;
Myers, R ;
Lemieux, L ;
Mitchell, TN ;
Brooks, DJ ;
Duncan, JS .
HUMAN BRAIN MAPPING, 2003, 19 (04) :224-247
[8]   18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease [J].
Harada, Ryuichi ;
Okamura, Nobuyuki ;
Furumoto, Shozo ;
Furukawa, Katsutoshi ;
Ishiki, Aiko ;
Tomita, Naoki ;
Tago, Tetsuro ;
Hiraoka, Kotaro ;
Watanuki, Shoichi ;
Shidahara, Miho ;
Miyake, Masayasu ;
Ishikawa, Yoichi ;
Matsuda, Rin ;
Inami, Akie ;
Yoshikawa, Takeo ;
Funaki, Yoshihito ;
Iwata, Ren ;
Tashiro, Manabu ;
Yanai, Kazuhiko ;
Arai, Hiroyuki ;
Kudo, Yukitsuka .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) :208-214
[9]   Consensus nomenclature for in vivo imaging of reversibly binding radioligands [J].
Innis, Robert B. ;
Cunningham, Vincent J. ;
Delforge, Jacques ;
Fujita, Masahiro ;
Giedde, Albert ;
Gunn, Roger N. ;
Holden, James ;
Houle, Sylvain ;
Huang, Sung-Cheng ;
Ichise, Masanori ;
Lida, Hidehiro ;
Ito, Hiroshi ;
Kimura, Yuichi ;
Koeppe, Robert A. ;
Knudsen, Gitte M. ;
Knuuti, Juhani ;
Lammertsma, Adriaan A. ;
Laruelle, Marc ;
Logan, Jean ;
Maguire, Ralph Paul ;
Mintun, Mark A. ;
Morris'o, Evan D. ;
Parsey, Ramin ;
Price, Julie C. ;
Slifstein, Mark ;
Sossi, Vesna ;
Suhara, Tetsuya ;
Votaw, John R. ;
Wong, Dean F. ;
Carson, Richard E. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (09) :1533-1539
[10]   Kinetic evaluation of [C-11]dihydrotetrabenazine by dynamic PET: Measurement of vesicular monoamine transporter [J].
Koeppe, RA ;
Frey, KA ;
VanderBorght, TM ;
Karlamangla, A ;
Jewett, DM ;
Lee, LC ;
Kilbourn, MR ;
Kuhl, DE .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (06) :1288-1299